The UK Health Security Agency (UKHSA) has confirmed a new case of Clade Ib mpox in England, stressing that the risk to the general public remains low.
The case was detected in East Sussex, southeast England, involving an individual who recently returned from Uganda, where community transmission of Clade Ib mpox is ongoing. The patient is receiving specialized care at Guy’s and St. Thomas’ NHS Foundation Trust in London.
Dr. Meera Chand, deputy director at UKHSA, praised the swift identification of the case. “Thanks to clinicians quickly recognizing the symptoms and the efforts of our specialist laboratory, we have been able to detect this new case,” she said.
“This marks the sixth case reported in England since October, but the risk to the UK population remains low. We are working promptly to trace close contacts and minimize any potential spread,” she added.
Tracing and Prevention Efforts
UKHSA is actively tracing and monitoring close contacts of the affected individual. Contacts will be offered testing, vaccinations if necessary, and guidance on further care should they develop symptoms or test positive.
Clade Ib mpox has been reported in several African countries, with imported cases detected in nations including India, Belgium, Canada, France, Germany, Sweden, and the United States.
Symptoms and Transmission
Mpox typically presents with symptoms such as a skin rash or pus-filled lesions lasting 2 to 4 weeks, along with fever, headaches, muscle aches, back pain, fatigue, and swollen lymph nodes. The virus spreads through close contact with an infected person or animal, or through contaminated materials.
UKHSA advises individuals experiencing symptoms to avoid contact with others while their symptoms persist.
Preparedness in the UK
The UKHSA has emphasized its preparedness to manage and respond to confirmed cases effectively. Extensive planning and training have been implemented to equip healthcare professionals to handle such cases promptly.
By identifying and managing cases early, health authorities aim to minimize transmission risks and ensure public safety.
